These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 27643871)
41. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Cheuk DK; Mok AS; Lee AC; Chiang AK; Ha SY; Lau YL; Chan GC Bone Marrow Transplant; 2008 Sep; 42(5):319-27. PubMed ID: 18560410 [TBL] [Abstract][Full Text] [Related]
42. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. Kataoka I; Kami M; Takahashi S; Kodera Y; Miyawaki S; Hirabayashi N; Okamoto S; Matsumoto N; Miyazaki Y; Morishita Y; Asai O; Maruta A; Yoshida T; Imamura M; Hamajima N; Matsuo K; Harada M; Mineishi S; Bone Marrow Transplant; 2004 Oct; 34(8):711-9. PubMed ID: 15361916 [TBL] [Abstract][Full Text] [Related]
43. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666 [TBL] [Abstract][Full Text] [Related]
44. The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry. Michallet M; Sobh M; Milligan D; Morisset S; Niederwieser D; Koza V; Ruutu T; Russell NH; Verdonck L; Dhedin N; Vitek A; Boogaerts M; Vindelov L; Finke J; Dubois V; van Biezen A; Brand R; de Witte T; Dreger P; Leukemia; 2010 Oct; 24(10):1725-31. PubMed ID: 20703257 [TBL] [Abstract][Full Text] [Related]
45. Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides. Gabriel IH; Olavarria E; Jones RR; Whittaker S; Chaidos A; Apperley JF Bone Marrow Transplant; 2007 Aug; 40(4):401-3. PubMed ID: 17589536 [No Abstract] [Full Text] [Related]
46. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652 [TBL] [Abstract][Full Text] [Related]
47. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin. Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582 [TBL] [Abstract][Full Text] [Related]
48. Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors. Kopp HG; Wirths S; Faul C; Bethge W; Scheding S; Brugger W; Kanz L; Vogel W J Cancer Res Clin Oncol; 2010 Dec; 136(12):1921-7. PubMed ID: 20217128 [TBL] [Abstract][Full Text] [Related]
49. Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially? Mehta J; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Singhal S Bone Marrow Transplant; 2006 Jul; 38(2):95-100. PubMed ID: 16751789 [TBL] [Abstract][Full Text] [Related]
50. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group. Yesilipek MA; Ertem M; Cetin M; Öniz H; Kansoy S; Tanyeli A; Anak S; Kurekci E; Hazar V Pediatr Transplant; 2012 Dec; 16(8):846-51. PubMed ID: 22931438 [TBL] [Abstract][Full Text] [Related]
51. Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran. Alimoghaddam K; Ghavamzadeh A; Jahani M; Jalali A; Jorjani H; Iravani M; Hamidieh AA; Mousavi A; Bahar B; Behfar M; Derakhshandeh R; Rostami S Arch Iran Med; 2011 Sep; 14(5):332-4. PubMed ID: 21888457 [TBL] [Abstract][Full Text] [Related]
52. Optimal Outcomes in Young Class 3 Patients With Thalassemia Undergoing HLA-Identical Sibling Bone Marrow Transplantation. Gaziev J; Isgrò A; Sodani P; Marziali M; Paciaroni K; Gallucci C; De Angelis G; Andreani M; Testi M; Alfieri C; Ribersani M; Galluccio T; Battarra MR; Morrone A; Lucarelli G Transplantation; 2016 Apr; 100(4):925-32. PubMed ID: 26457600 [TBL] [Abstract][Full Text] [Related]